Eyenovia Provides Update on Phase 3 CHAPERONE Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Brookline Capital Markets Downgrades Eyenovia (EYEN) to Hold
November 15, 2024 9:24 AM ESTBrookline Capital Markets analyst Kemp Dolliver downgraded Eyenovia (NASDAQ: EYEN) from Buy to Hold.
The analyst comments "EYEN announced this morning that CHAPERONEs Independent Review Committee determined that the trial failed to meet the primary efficacy endpoint. As a result, the company will... More
